We are live on ! Find out more
CBIO

Crescent Biopharma

49 hedge funds and large institutions have $52.1M invested in Crescent Biopharma in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,155% more call options, than puts

Call options by funds: $389K | Put options by funds: $31K

0.01% less ownership

Funds ownership: 0.55%0.54% (-0.01%)

11% less funds holding

Funds holding: 5549 (-6)

16% less capital invested

Capital invested by funds: $61.9M → $52.1M (-$9.84M)

53% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 17

55% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 11

Holders
49
Holders Change
-6
Holders Change %
-10.91%
% of All Funds
0.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
8
Reduced
17
Closed
11
Calls
$389K
Puts
$31K
Net Calls
+$358K
Net Calls Change
+$231K
Name Holding Trade Value Shares
Change
Change in
Stake
Truist Financial
51
Truist Financial
North Carolina
-$176K -1,010 Closed
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
-$66.4K -421 Closed
SWP
53
Stratos Wealth Partners
Ohio
-$58K -333 Closed
Simplex Trading
54
Simplex Trading
Illinois
-$28.9K -183 Closed
TSS
55
Two Sigma Securities
New York
-$19.1K -110 Closed
UBS Group
56
UBS Group
Switzerland
-$11K -63 Closed
Citadel Advisors
57
Citadel Advisors
Florida
-$3.59K -21 Closed
IPW
58
Impact Partnership Wealth
Georgia
-$1K -6 Closed
CWC
59
Carolinas Wealth Consulting
North Carolina
-$687 -4 Closed